regulatory
confidence high
sentiment positive
materiality 0.65
Dogwood Therapeutics regains Nasdaq minimum equity compliance after $19.9M debt swap and $4.8M offering
Dogwood Therapeutics, Inc.
- Regained compliance with Nasdaq minimum stockholders' equity requirement ($2.5M).
- Debt exchange with Conjoint canceled ~$19.9M debt for Series A-1 preferred stock.
- Stock offering raised ~$4.8M gross proceeds from institutional investors.
- Cash position $17.5M as of Q1 2025, no debt.
- Shares outstanding: 1,911,128 as of March 31, 2025.